25(OH)D Levels in Infancy Is Associated With Celiac Disease Autoimmunity in At-Risk Children: A Case–Control Study
Objectives: An observed variation in the risk of celiac disease, according to the season of birth, suggests that vitamin D may affect the development of the disease. The aim of this study was to investigate if vitamin D concentration is associated with the risk of celiac disease autoimmunity (CDA) i...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2021.720041/full |
id |
doaj-fb87afd0cc7949bcb14eb57ca9a3748e |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Carin Andrén Aronsson Xiang Liu Jill M. Norris Ulla Uusitalo Martha D. Butterworth Sibylle Koletzko Sibylle Koletzko Suvi M. Virtanen Suvi M. Virtanen Suvi M. Virtanen Iris Erlund Kalle Kurppa Kalle Kurppa Kalle Kurppa Kalle Kurppa William A. Hagopian Marian J. Rewers Jin-Xiong She Jorma Toppari Jorma Toppari Anette-G. Ziegler Beena Akolkar Jeffrey P. Krischer Daniel Agardh |
spellingShingle |
Carin Andrén Aronsson Xiang Liu Jill M. Norris Ulla Uusitalo Martha D. Butterworth Sibylle Koletzko Sibylle Koletzko Suvi M. Virtanen Suvi M. Virtanen Suvi M. Virtanen Iris Erlund Kalle Kurppa Kalle Kurppa Kalle Kurppa Kalle Kurppa William A. Hagopian Marian J. Rewers Jin-Xiong She Jorma Toppari Jorma Toppari Anette-G. Ziegler Beena Akolkar Jeffrey P. Krischer Daniel Agardh 25(OH)D Levels in Infancy Is Associated With Celiac Disease Autoimmunity in At-Risk Children: A Case–Control Study Frontiers in Nutrition celiac disease autoimmunity infants children vitamin D TEDDY celiac disease |
author_facet |
Carin Andrén Aronsson Xiang Liu Jill M. Norris Ulla Uusitalo Martha D. Butterworth Sibylle Koletzko Sibylle Koletzko Suvi M. Virtanen Suvi M. Virtanen Suvi M. Virtanen Iris Erlund Kalle Kurppa Kalle Kurppa Kalle Kurppa Kalle Kurppa William A. Hagopian Marian J. Rewers Jin-Xiong She Jorma Toppari Jorma Toppari Anette-G. Ziegler Beena Akolkar Jeffrey P. Krischer Daniel Agardh |
author_sort |
Carin Andrén Aronsson |
title |
25(OH)D Levels in Infancy Is Associated With Celiac Disease Autoimmunity in At-Risk Children: A Case–Control Study |
title_short |
25(OH)D Levels in Infancy Is Associated With Celiac Disease Autoimmunity in At-Risk Children: A Case–Control Study |
title_full |
25(OH)D Levels in Infancy Is Associated With Celiac Disease Autoimmunity in At-Risk Children: A Case–Control Study |
title_fullStr |
25(OH)D Levels in Infancy Is Associated With Celiac Disease Autoimmunity in At-Risk Children: A Case–Control Study |
title_full_unstemmed |
25(OH)D Levels in Infancy Is Associated With Celiac Disease Autoimmunity in At-Risk Children: A Case–Control Study |
title_sort |
25(oh)d levels in infancy is associated with celiac disease autoimmunity in at-risk children: a case–control study |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Nutrition |
issn |
2296-861X |
publishDate |
2021-08-01 |
description |
Objectives: An observed variation in the risk of celiac disease, according to the season of birth, suggests that vitamin D may affect the development of the disease. The aim of this study was to investigate if vitamin D concentration is associated with the risk of celiac disease autoimmunity (CDA) in genetically at-risk children.Study Design: Children prospectively followed in the multinational The Environmental Determinants of Diabetes in the Young study, conducted at six centers in Europe and the US, were selected for a 1-to-3 nested case–control study. In total, 281 case–control sets were identified. CDA was defined as positivity for tissue transglutaminase autoantibodies (tTGA) on two or more consecutive visits. Vitamin D was measured as 25-hydroxyvitamin D [25(OH)D] concentrations in all plasma samples prior to, and including, the first tTGA positive visit. Conditional logistic regression was used to examine the association between 25(OH)D and risk of CDA.Results: No significant association was seen between 25(OH)D concentrations (per 5 nmol/L increase) and risk for CDA development during early infancy (odds ratio [OR] 0.99, 95% confidence interval [CI] 0.95–1.04) or childhood (OR 1.02, 95% CI 0.97–1.07). When categorizing 25(OH)D concentrations, there was an increased risk of CDA with 25(OH)D concentrations <30 nmol/L (OR 2.23, 95% CI 1.29, 3.84) and >75 nmol/L (OR 2.10, 95% CI 1.28–3.44) in early infancy, as compared with 50–75 nmol/L.Conclusion: This study indicates that 25(OH)D concentrations <30 nmol/L and >75 nmol/L during early infancy were associated with an increased risk of developing CDA in genetically at-risk children. The non-linear relationship raises the need for more studies on the possible role of 25(OH)D in the relation to celiac disease onset. |
topic |
celiac disease autoimmunity infants children vitamin D TEDDY celiac disease |
url |
https://www.frontiersin.org/articles/10.3389/fnut.2021.720041/full |
work_keys_str_mv |
AT carinandrenaronsson 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT xiangliu 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT jillmnorris 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT ullauusitalo 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT marthadbutterworth 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT sibyllekoletzko 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT sibyllekoletzko 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT suvimvirtanen 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT suvimvirtanen 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT suvimvirtanen 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT iriserlund 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT kallekurppa 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT kallekurppa 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT kallekurppa 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT kallekurppa 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT williamahagopian 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT marianjrewers 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT jinxiongshe 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT jormatoppari 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT jormatoppari 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT anettegziegler 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT beenaakolkar 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT jeffreypkrischer 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy AT danielagardh 25ohdlevelsininfancyisassociatedwithceliacdiseaseautoimmunityinatriskchildrenacasecontrolstudy |
_version_ |
1716865528955404288 |
spelling |
doaj-fb87afd0cc7949bcb14eb57ca9a3748e2021-09-28T14:51:33ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2021-08-01810.3389/fnut.2021.72004172004125(OH)D Levels in Infancy Is Associated With Celiac Disease Autoimmunity in At-Risk Children: A Case–Control StudyCarin Andrén Aronsson0Xiang Liu1Jill M. Norris2Ulla Uusitalo3Martha D. Butterworth4Sibylle Koletzko5Sibylle Koletzko6Suvi M. Virtanen7Suvi M. Virtanen8Suvi M. Virtanen9Iris Erlund10Kalle Kurppa11Kalle Kurppa12Kalle Kurppa13Kalle Kurppa14William A. Hagopian15Marian J. Rewers16Jin-Xiong She17Jorma Toppari18Jorma Toppari19Anette-G. Ziegler20Beena Akolkar21Jeffrey P. Krischer22Daniel Agardh23Department of Clinical Sciences, Lund University, Malmö, SwedenDepartment of Pediatrics, Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, United StatesDepartment of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, CO, United StatesDepartment of Pediatrics, Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, United StatesDepartment of Pediatrics, Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, United StatesDr. von Hauner Children's Hospital, Ludwig Maximilians University, Munich, GermanyDepartment of Pediatrics, Gastroenterology and Nutrition, School of Medicine Collegium, Medicum University of Warmia and Mazury, Olsztyn, PolandDepartment of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, FinlandUnit of Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, FinlandCenter for Child Health Research, Tampere University, Tampere, FinlandDepartment of Government Services, Finnish Institute for Health and Welfare, Helsinki, Finland0Tampere Center for Child Health Research, Tampere University, Tampere, Finland1Department of Pediatrics, Tampere University Hospital, Tampere, Finland2The University Consortium of Seinäjoki, Seinäjoki, Finland3Department of Pediatrics, Seinäjoki Central Hospital, Seinäjoki, Finland4Pacific Northwest Research Institute, Seattle, WA, United States5Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, CO, United States6Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA, United States7Department of Pediatrics, Turku University Hospital, Turku, Finland8Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, Centre for Population Health Research, University of Turku, Turku, Finland9Institute of Diabetes Research, Helmholtz Zentrum München, Klinikum rechts der Isar, Technische Universität München, and Forschergruppe Diabetes e.V., Neuherberg, Germany0National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, United StatesDepartment of Pediatrics, Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, United StatesDepartment of Clinical Sciences, Lund University, Malmö, SwedenObjectives: An observed variation in the risk of celiac disease, according to the season of birth, suggests that vitamin D may affect the development of the disease. The aim of this study was to investigate if vitamin D concentration is associated with the risk of celiac disease autoimmunity (CDA) in genetically at-risk children.Study Design: Children prospectively followed in the multinational The Environmental Determinants of Diabetes in the Young study, conducted at six centers in Europe and the US, were selected for a 1-to-3 nested case–control study. In total, 281 case–control sets were identified. CDA was defined as positivity for tissue transglutaminase autoantibodies (tTGA) on two or more consecutive visits. Vitamin D was measured as 25-hydroxyvitamin D [25(OH)D] concentrations in all plasma samples prior to, and including, the first tTGA positive visit. Conditional logistic regression was used to examine the association between 25(OH)D and risk of CDA.Results: No significant association was seen between 25(OH)D concentrations (per 5 nmol/L increase) and risk for CDA development during early infancy (odds ratio [OR] 0.99, 95% confidence interval [CI] 0.95–1.04) or childhood (OR 1.02, 95% CI 0.97–1.07). When categorizing 25(OH)D concentrations, there was an increased risk of CDA with 25(OH)D concentrations <30 nmol/L (OR 2.23, 95% CI 1.29, 3.84) and >75 nmol/L (OR 2.10, 95% CI 1.28–3.44) in early infancy, as compared with 50–75 nmol/L.Conclusion: This study indicates that 25(OH)D concentrations <30 nmol/L and >75 nmol/L during early infancy were associated with an increased risk of developing CDA in genetically at-risk children. The non-linear relationship raises the need for more studies on the possible role of 25(OH)D in the relation to celiac disease onset.https://www.frontiersin.org/articles/10.3389/fnut.2021.720041/fullceliac disease autoimmunityinfantschildrenvitamin DTEDDYceliac disease |